news Archives - DelveInsight

news

recent-pharma-news-for-biogen-phathom-vertex-natera
Biogen’s ALS drug Tofersen (BIIB067); Phathom’s erosive esophagitis drug trial; Verte...

Biogen’s tofersen fails to meet the primary goal in the Phase III ALS trialBiogen has announced that its investigational antisense drug, tofersen (BIIB067), flunked to meet the primary goal of...


medtech-news-updtes-updates-for-syntellix-bausch-lomb-movair-cochlear-laborie
Bausch + Lomb’s LuxSmart Intraocular Lenses; Movair’s Luisa Life Supporting Ventilato...

Syntellix obtains product approval for IndiaOn October 07, 2021, Syntellix obtained the license to bring five different product families of its revolutionary bioabsorbable magnesium-based impl...


recent-biotech-pharma-news-for-brickell-bms-amydis-gensight-cybrexa
Brickell to Submit New Drug Application to FDA; Twin Health Raises $140M; BMS’ Deucravaciti...

Brickell Plans to Submit New Drug Application to FDA for gelBrickell Biotech will request the FDA in mid-2022 to approve its gel for excessive underarm sweating after decreasing sweat producti...


medtech-news-updates-for-iotamotion-recor-natera-boston-scientific
Amber Implants VCFix spinal system; iotaMotion’s iotaSOFT Insertion System; Boston Scientif...

Amber Implants VCFix® spinal system obtains US FDA Breakthrough designation On October 05, 2021, the US Food and Drug Administration (FDA) granted the Breakthrough Device Designation to V...


pharma-biotech-news-updates-for-pfizer-kytopen-eli-lilly-vensana-reify-health
Pfizer tightens DMD trial criteria over safety concerns; Kytopen raises $30M; Eli Lilly taps Reif...

Pfizer tightens DMD patient criteria after serious adverse events in phase 3 gene therapy trialPfizer is tightening up the criteria for Duchenne muscular dystrophy patients to partake in phase...


medtech-happenings-for-neurolief-paige-bionaut-retina-medtronic
RETINA-AI Health declares positive results; Medtronic’s Hugo robotic-assisted surgery syste...

RETINA-AI Health, Inc. declares positive pivotal study results for the RETINA-AI Galaxy™ autonomous Diabetic Retinopathy screening deviceOn September 20, 2021, RETINA-AI Health, Inc. an...


pharma-biotech-news-updates-for-innovent-biohaven-delix-intracellular-therapies
UNION Therapeutics-Innovent’s collaboration; Delix Therapeutics bags $ 70 M; Biohaven’s Ver...

Innovent, UNION Therapeutics Set to Advance Dermatology Market in China Innovent Biologics and UNION therapeutics have announced a strategic and licensing collaboration to develop and com...


pharma-biotech-news-updates-for-novartis-boston-scientific-boehringer-ingelheim
Boston Scientific pays $336M; Boehringer Ingelheim acquires Abexxa Biologics; Oncology, RNA biote...

Boston Scientific pays USD 336 Million to acquire blood clot medical device firmBoston Scientific Corp. is shelling out as much as USD 336 million to take over the rest of medical device firm ...


pharma-biotech-news-updates-for-biogen-smartlabs-synlogic-partner-therapeutics
Biogen’s AMD Biosimilar Gets Approval; SmartLabs Series B Funding; BARDA, Partner Therapeutics in...

Win-win for Biogen as its Biosimilar Gets Approval for AMD Samsung Bioepis and Biogen's biosimilar drug, Byooviz, received USFDA approval for the treatment of vision loss, Age-related mac...


pharma-happenings-for-amylyx-beigene-roche-temedic-sage-therapeutics
FDA’s New Drug Application to ALS Drug; Approval to BeiGene’s Brukinsa; Roche, Temedica Forges D...

FDA’s Go-Ahead to Amylyx New Drug Application for ALS Drug Amylyx Pharmaceuticals has announced its plan to submit a New Drug Application (NDA) to the U.S. FDA for its drug, AMX0035 (sodi...


Editor's Pick
Discover How Learning Disability Treatment Landscape is Evolving with the Eme...

A Learning Disability (LD) is a neurological condition resulting from genetic and neuro...

Development of Gene Therapies in Dermatology

What is Gene Therapy and Is the Skin Suitable for Gene Therapy? Since its first discove...

Mapping the Increasing Burden of Heart Failure: What Does it Bring for Health...

Heart failure (HF), also referred to as Congestive Heart failure (CHF), is a condition ...

Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.